OCULUS VENTURES CORPORATION
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 This Management Discussion and Analysis (“MD&A”) of Oculus Ventures Corporation (“Oculus” or the “Company” or “Issuer”) has been prepared by management as of May 30, 2014. This MD&A should be read in conjunction with the unaudited condensed interim financial statements and notes thereto for the three months ended March 31, 2014 and with the audited consolidated financial statements for the fiscal year ended December 31, 2013 and related notes . Forward Looking Information This MD&A may contain “forward-looking statements” which reflect the Company’s current expectations regarding the future results of operations, performance and achievements of the Issuer. The Issuer has tried, wherever possible, to identify these forward-looking statements by, among other things, using words such as “anticipate,” “believe,” “estimate,” “expect” and similar expressions. The statements reflect the current beliefs of the management of the Company, and are based on currently available information. Accordingly, these statements are subject to known and unknown risks, uncertainties and other factors, which could cause the actual results, performance, or achievements of the Issuer to differ materially from those expressed in, or implied by, these statements. The Company undertakes no obligation to publicly update or review the forward-looking statements whether as a result of new information, future events or otherwise. Historical results of operations and trends that may be inferred from the following discussions and analysis may not necessarily indicate future results from operations. Overall Performance The Company was incorporated under the Canadian Business Corporations Act on May 8, 2007 and became a Capital Pool Company (“CPC”) as defined in Policy 2.4 of the TSX Venture Exchange (the “TSXV”) on March 1, 2008. As a CPC, the Company’s principal business is to identify, evaluate and acquire assets, properties or businesses which would constitute a Qualifying Transaction (“QT”) in accordance with Policy 2.4 of the TSXV. Such a transaction will be subject to shareholder and regulatory approval. On March 25, 2008, the Company completed its Initial Public Offering (“Offering”) and issued 4,000,000 Class A Shares at $0.10 per share, for gross proceeds of $400,000. The net proceeds of this Offering are being used to provide the Company with a minimum of funds with which to identify and evaluate assets or businesses for acquisition with a view to completing a Qualifying Transaction. On April 1, 2008, the Company’s Class A Shares commenced trading on the Exchange under the trading symbol “OVX.P”. On April 1, 2010, the Company received notice from the TSXV that it had been suspended from trading for failure to complete a Qualifying Transaction (QT) within the 24 months of listing with the Exchange, in accordance with Exchange Policy 2.4. On July 16, 2010, Oculus Ventures Corporation shares were listed on the NEX under the symbol OVX.H and trading was reinstated on the opening of July 19, 2010. Pursuant to Section 4.1(1)(b)(ii) of the Escrow Agreement which states that, if the Company fails to complete its Qualifying Transaction within the time period specified by the Exchange and is moved to the NEX, the Company and the Escrow Agent shall “take such action as is necessary to immediately cancel that number of Discount Seed Shares held by Related Parties to the CPC as determined by a vote of the shareholders of the Issuer pursuant to section 14.13 of the Policy”, on July 6, 2010 the Company issued a Treasury Order cancelling 1,000,000 of the seed shares owned by BBG Equity Management Corporation. On February 22, 2011, the Company increased the size of the Board of Directors to six and Robert Bryniak, Leigh Stewart, Gunther Roehlig, Dorian Banks, Mark Newman and Darren Devine were elected to serve on the Board. David Croucher and John Gabriel resigned as Directors and Officers. 1
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 On February 22, 2011, the Company altered the names of the Class A Shares to Common Shares and Class B Shares to Preferred Shares and completed a consolidation of the issued and outstanding Common Shares on the basis of one for four issued and outstanding Common Shares. On March 11, 2011, the Company completed a private placement whereby it issued 14,000,000 Common Shares for $0.05 per share for gross proceeds of $700,000. As part of the financing, the Company issued 1,400,000 shares as a finders fee. On March 11, 2011, the stock options of the former directors of the Company were cancelled. On April 17, 2012, Dorian Banks resigned as President and Chief Executive Officer of the Company and was replaced Morgan Tincher. On November 26, 2012, the Company announced that Mark Newman had resigned as a Director and CFO and that Darren Devine had replaced Mr. Newman as CFO. At the same time, the Company approved a transfer of 104,376 post-consolidation Shares between directors of the Company. On December 10, 2012, the Company entered into a non-binding letter of intent (“LOI”), whereby the Company’s wholly owned subsidiary Canemir Petroleum (BVI) Holdings Corp. (“Canemir”) may have the rights to earn up to an 85% interest in a Petroleum Concession Agreement (“PCA”) over oil and gas exploration acreage in the Emirate of Umm Al Quwain, United Arab Emirates (“UAE”). On December 11, 2012, the Company incorporated, in the British Virgin Islands, a wholly owned subsidiary named Canemir Petroleum (BVI) Holdings Corp. On March 18, 2013, the Company entered into an option agreement (the “Option Agreement”) with Quest Oil & Gas Ventures Inc. (“Quest”) to acquire an interest in an oil and gas exploration and production concession in UAE. Due to inability to complete a minimum financing of U$11,000,000 by May 12, 2013, this option agreement is currently not in good standing. On September 30, 2013, the Company terminated its option agreement with Quest. On March 6, 2014, the Company’s wholly-owned subsidiary, Canemir, was dissolved. On March 6, 2014, the Company completed a non-brokered private placement for 10,000,000 common shares at $0.05 per share for gross proceeds of $500,000. On April 4, 2014, the Company incorporated a wholly-owned subsidiary, 1813472 Alberta Ltd. On April 21, 2014, the Company entered into an Amalgamation Agreement with Slyce Inc., whereby the Company’s wholly-owned subsidiary, 1814572 Alberta Ltd. and Slyce Inc. will amalgamate to form one company which will be a wholly-owned subsidiary of the Company. See Subsequent Events for details of the agreement. The Company has no commercial operations and no significant assets other than cash. As at March 31, 2014, the Company had cash of $439,771 and current working capital of $386,857, no revenues, loss for the three months ended March 31, 2014 of $14,949 and accumulated losses since inception of $1,219,198. Accordingly, there is substantial doubt that the Company will be able to continue as a going concern without incremental financing. The Company’s financial statements for the period ended March 31, 2014 do not include any adjustments related to recoverability and classification of recorded amounts, or the amounts and classification of liabilities that might be necessary should the Company be unable to continue its operations. 2
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 Recent Financings – Use of Proceeds The following is a summary of the recent financings completed by the Company, purpose for which the funds were raised, actual use of proceeds and explanation of any discrepancies. Financing Purpose of the Financing Actual Use of Proceeds March 6, 2014 To finance qualifying transaction and The Company paid $1,263 of share issuance non-brokered general working capital costs in connection with this private financing of requirements. placement. $500,000 $67,152 was used to pay down accounts payable. The remaining $431,585 from the financing are held as working capital and will be used by the Company for identifying and completing a qualifying transaction and for working capital purposes. Additional Disclosure for Venture Issuers Without Significant Revenue The following is a breakdown of the property investigation costs: Three Months Three Months ended ended March 31, 2014 March 31, 2013 Property investigation costs 51-101 report $ - $ 12,545 Accounting and tax - 6,873 Consulting - 12,029 Filing - 2,800 Legal 5,634 51,389 Sponsorship fees - 25,000 Travel - 21,451 $ 5,634 $ 132,087 Property investigation costs relate to investigation and due diligence on a proposed transaction to acquire on option to earn an 85% economic interest in a Petroleum Concession Agreement over oil and gas exploration acreage in the United Arab Emirates. This proposed transaction was terminated on September 30, 2013. Results of Operations The Company has not completed its Qualifying Transaction to acquire a business or asset and, as such, its only activities relate to regulatory compliance and identifying a suitable target for the Qualifying Transaction. Quarter ended March 31, 2014 (“Q1 2014”) compared with quarter ended March 31, 2013 (“Q1 2013”) During the three months ended March 31, 2014, the Company recorded a net loss of $14,949 compared to a net loss of $160,029 for the same period ended March 31, 2013. The $145,080 decrease was primarily due to the termination of the Company’s option to earn up to an 85% interest in a Petroleum Concession Agreement over oil and gas exploration acreage in the Emirate of Umm Al Quwain, United Arab Emirates. Significant cost variances are as follows: 3
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 • General and administrative costs decreased from $9,018 in Q1 2013 to $3,127 in Q1 2014. The decrease was due to decrease in promotion and office expenses; • Property investigation costs decreased from $132,087 in Q1 2013 to $5,634 in Q1 2014. The decrease was due to the termination of the Company’s option agreement with Quest; • Rent expense was $1,500 in Q1 2014 compared with $4,500 in Q1 2013. Decrease in rent is due to decrease in monthly rent expenses; and • Transfer agent and filing fees decreased from $8,982 in Q1 2013 to $3,599 in Q1 2014. The decrease was due to decrease in public filings from Q1 2013 to Q1 2014. Summary of Quarterly Results Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2 2014 2013 2013 2013 2013 2012 2012 2012 Net loss for the period $14,949 $17,337 $5,339 $55,575 $160,029 $165,857 $40,081 $35,730 Loss per share $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.01 $ 0.01 $ 0.00 $ 0.00 Net losses for Q1 2013 and Q4 2012 are significantly higher than losses for the previous quarters due to incurring property investigation costs of $132,087 in Q1 2013 and $56,715 in Q4 2012 in connection with identification and investigation of an option to earn up to an 85% interest in a Petroleum Concession Agreement (“PCA”) over oil and gas exploration acreage in the Emirate of Umm Al Quwain, United Arab Emirates. In Q2 2013, the Company also incurred other costs related to the oil and gas option agreement such as legal, audit and accounting, filing fees and 51-101 report preparation costs. Net loss in Q3 2013, Q4 2013 and Q1 2014 was significantly lower due to the termination of the Qualifying Transaction with Quest. Liquidity and Capital Resources Working Capital As of March 31, 2014, the Company’s working capital was $386,857 compared to $96,931 working capital deficiency as of December 31, 2013. Increase in working capital by $483,788 is mainly due to raising proceeds of $500,000 from share issuance, offset by the current quarter’s operating losses. Cash and Cash Equivalents As of March 31, 2014, the Company had cash of $439,771 compared to cash of $8,442 as at December 31, 2013. Management of cash balances is conducted in-house based on internal investment guidelines, which generally specify that investments be made in conservative money market instruments that bear and carry a low degree of risk. Some examples of instruments in which the Company may invest its cash are treasury bills, money market funds, bank guaranteed investment certificates and bankers' acceptance notes. The objective of these investments is to preserve funds for identifying and investigating potential targets for the Company’s Qualifying Transaction. 4
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 Cash Used in Operating Activities Cash used in operating activities during the three months ended March 31, 2014 was $68,171 (March 31, 2013 - $132,407). Cash was mostly spent on general and administrative expenses, property investigation costs, filing and transfer agent fees, along with paying down accounts payable. Decrease in cash used in operating activities is due to incurring $132,087 of property investigation costs during the three months ended March 31, 2013, compared with $5,634 incurred during the three months ended March 31, 2014. Cash Used in Investing Activities The Company did not have any investing activities during the three months ended March 31, 2014 and 2013. Cash Generated by Financing Activities During the three months ended March 31, 2014, the Company received cash proceeds of $500,000 from the issuance of 10,000,000 common shares at $0.05 per share. There were no financing activities in the three months ended March 31, 2013. Requirement of Additional Equity Financing The Company relies primarily on equity financings for all funds raised to date for its operations. The Company may need more funds to secure its acquisition of businesses or assets. The Company intends to continue relying upon the issuance of securities to finance its operations and acquisitions. Off-Balance Sheet Arrangements The Company does not utilize off-balance sheet arrangements. Transactions with Related Parties The Company’s related parties and key management personnel consist of the Company’s directors and officers and CDM Capital Corp., a company partially owned by a director and officer of the Company. During the three months ended March 31, 2014, the Company recorded $1,500 (2013 - $4,500) of office rent and $3,000 (2013 - $4,500) of general and administrative expenses to CDM Capital Corp. Subsequent Events a) On April 4, 2014, the Company incorporated a wholly-owned subsidiary, 1813472 Alberta Ltd. b) On April 21, 2014, the Company entered into an definitive amalgamation agreement (the “Amalgamation Agreement”) where by Slyce Inc. (“Slyce”) and a wholly-owned subsidiary of the Company, 1813472 Alberta Ltd., will amalgamate to form one Alberta corporation which will be a wholly-owned subsidiary of the Company and which will continue to operate the business of Slyce (the “Transaction”). In connection with the Amalgamation, the Company will change its name to Slyce Inc. (“New Slyce”). Immediately prior to the Amalgamation, the Company will consolidate its 26,650,002 issued and outstanding common shares at a ratio of 1 post-consolidation share for each 1.75 pre- consolidation share. The acquisition by the Company of all the issued and outstanding Slyce Class “A”, Class “B”, Class “C”, Class “D”, Class “E” and Class “F” common shares (“Slyce Common Shares”) will be on the 5
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 basis of 1.2168 Oculus shares (“New Slyce Common Share”) for each 1 Slyce common share held representing the issuance of approximately 60,000,000 New Slyce Common Shares. This represents a deemed share price of $0.60 per Slyce Common Share and Oculus post-consolidation common share ($0.34 per pre-consolidated Oculus shares), representing a total deemed transaction value of $36,000,000 for Slyce. Issued and outstanding options and warrants of Slyce will be deemed to represent issued and outstanding options and warrants of New Slyce on an adjusted basis at the same valuation. Upon completion of the Transaction all of the current directors and officers of the Company will resign. The Transaction will be the Company’s “Qualifying Transaction” in accordance with TSXV and is subject to the approval of the TSXV and all applicable regulatory authorities. Slyce has entered into an engagement letter with Canaccord Genuity Corp. (“Canaccord”), on behalf of a syndicate of agents (the “Agents”) to assist in a brokered private placement to raise gross proceeds of up to $10 million (the “Offering”) through the issuance of subscription receipts (“Subscription Receipts”) of Slyce at a price of $0.60 per Subscription Receipt. In addition, the Agents will have an overallotment option to raise additional gross proceeds of up to $2 million, exercisable 48 hours prior to closing. Upon satisfaction of all conditions to the completion of the Amalgamation in accordance with the Amalgamation Agreement including the receipt of all required shareholder and regulatory approvals, each Subscription Receipt will automatically convert into that number of Slyce Common Shares equal to one New Slyce Common Share. In connection with the Offering, Slyce has agreed to pay the Agents a commission equal to 6% of the total gross proceeds raised by the Offering and issue Agents warrants to acquire New Slyce Common Shares equal to 6% of the Subscription Receipts sold under the Offering. The warrants will be exercisable up to two years from date of closing at $0.60 per New Slyce Common Share. The Transaction is an arms-length transaction pursuant to the policies of the TSXV. The Transaction is scheduled for completion on or before June 30, 2014. Proposed Transactions See Subsequent Events for details of proposed transactions. Accounting Standards Issued but Not Yet Effective Certain new standards, interpretations and amendments to existing standards have been issued by the IASB or IFRIC that are mandatory for current and future accounting periods. New standard IFRS 9 “Financial Instruments” This new standard is a partial replacement of IAS 39 “Financial Instruments: Recognition and Measurement”. IFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost or fair value, replacing the multiple rules in IAS 39. The approach in IFRS 9 is based on how an entity manages its financial instruments in the context of its business model and the contractual cash flow characteristics of the financial assets. The new standard also requires a single impairment method to be used, replacing the multiple impairment methods in IAS 39. The effective date of IFRS 9 has not been specified. 6
OCULUS VENTURES CORPORATION MANAGEMENT DISCUSSION & ANALYSIS For the period ended March 31, 2014 Amendments to IAS 32 “Financial Instruments: Presentation” These amendments address inconsistencies when applying the offsetting requirements, and is effective for annual periods beginning on or after January 1, 2014. The Company has not early adopted these revised standards and is currently assessing the impact that these standards will have on its financial statements. Other accounting standards or amendments to existing accounting standards that have been issued but have future effective dates are either not applicable or are not expected to have a significant impact on the Company’s financial statements. Financial Instruments and Other Instruments The fair value of the Company’s financial assets and liabilities approximates the carrying amount. Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to the relative reliability of the inputs used to estimate the fair values. The three levels of the fair value hierarchy are: • Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities; • Level 2 – Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and • Level 3 – Inputs that are not based on observable market data. The Company’s cash has been assessed on the fair value hierarchy described above and classified as Level 1. Other Requirements Summary of Outstanding Share Data: The Company’s authorized share capital consists of an unlimited number of common shares without par value. As of March 31, 2014, the Company had 26,650,002 common shares issued and outstanding and no share purchase options or share purchase warrants outstanding. Risks and Uncertainties The Company has no active business or significant assets other than cash. It does not have a history of earnings, nor has it paid any dividends and will not generate earnings or pay dividends until at least after the completion of a QT. The directors and officers of the Company will only devote part of their time and attention to the affairs of the Company and some of them are or will be engaged in other projects or businesses that could give rise to potential conflicts of interest. There is no assurance that there will be an active and liquid market for the Company’s common shares. The Company has only limited funds with which to identify and evaluate potential QTs and there can be no assurance that the Company will be able to identify or complete a QT acceptable to the Exchange. Additional disclosures pertaining to the Company’s technical report, management information circulars, material change reports, press releases and other information are available on the SEDAR website at www.sedar.com. 7
You can also read